Compounds > indazoles
Page last updated: 2024-08-21

indazoles and Animal Mammary Carcinoma

indazoles has been researched along with Animal Mammary Carcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexandre, PA; Cordeiro, YG; Fukumasu, H; Müller, S; Pires, PRL; Saranholi, BH; Silva, ER; Xavier, PLP1
Davis, JM; Guglielmotti, A; McClellan, JL; Murphy, EA; Steiner, JL1
Bernhard, EJ; Im, J; McKenna, WG; Muschel, RJ; Qayum, N; Stratford, MR1
Benakanakere, I; Besch-Williford, C; Carroll, CE; Hyder, SM; Liang, Y1
Epelbaum, R; Frei, E; Herman, TS; Holden, SA; Liu, SD; Teicher, BA1

Other Studies

5 other study(ies) available for indazoles and Animal Mammary Carcinoma

ArticleYear
An epigenetic screening determines BET proteins as targets to suppress self-renewal and tumorigenicity in canine mammary cancer cells.
    Scientific reports, 2019, 11-22, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents; Azepines; Biomarkers, Tumor; Carcinogenesis; Cell Proliferation; Dog Diseases; Dogs; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Testing; Indazoles; Mammary Neoplasms, Animal; Multigene Family; Neoplastic Stem Cells; Pyridones; Transcription Factors; Triazoles

2019
Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
    Cytokine, 2014, Volume: 66, Issue:1

    Topics: Animals; Antigens, Polyomavirus Transforming; Biomarkers; Body Weight; Carcinogenesis; Chemokine CCL2; Disease Models, Animal; Feeding Behavior; Female; Gene Expression Regulation; Indazoles; Inflammation Mediators; Interleukin-6; Macrophages; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Organ Size; Propionates; RNA, Messenger; Spleen; Tumor Burden; Tumor Necrosis Factor-alpha

2014
Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Jan-01, Volume: 18, Issue:1

    Topics: Animals; Doxorubicin; Drug Delivery Systems; Female; Humans; Hypoxia; Immunoenzyme Techniques; Indazoles; Mammary Neoplasms, Animal; Mice; Mice, Nude; Mice, Transgenic; Microvessels; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Sulfonamides

2012
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.
    International journal of oncology, 2013, Volume: 42, Issue:1

    Topics: Animals; Anthracenes; Apoptosis; Blotting, Western; Cell Proliferation; Enzyme Activators; Enzyme-Linked Immunosorbent Assay; Female; Guanylate Cyclase; Hormone Antagonists; Humans; Immunoenzyme Techniques; Indazoles; Mammary Neoplasms, Animal; Mice; Mice, Nude; Mifepristone; Piperidines; Progestins; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2013
Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Cancer research, 1991, Feb-01, Volume: 51, Issue:3

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carboplatin; Carmustine; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Fibrosarcoma; Humans; Indazoles; Mammary Neoplasms, Animal; Mice; Organoplatinum Compounds; Tumor Cells, Cultured; Tumor Stem Cell Assay

1991